{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:45:30Z","timestamp":1769150730970,"version":"3.49.0"},"reference-count":42,"publisher":"Impact Journals, LLC","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,26]]},"DOI":"10.18632\/oncotarget.20480","type":"journal-article","created":{"date-parts":[[2017,8,26]],"date-time":"2017-08-26T12:58:27Z","timestamp":1503752307000},"page":"74975-74986","source":"Crossref","is-referenced-by-count":17,"title":["Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma"],"prefix":"10.18632","volume":"8","author":[{"given":"Jongheon","family":"Jung","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, National Cancer Center, Goyang, Korea"},{"name":"Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyewon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cancer Center, Goyang, Korea"},{"name":"Center for Hematologic Malignancy, National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tak","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cancer Center, Goyang, Korea"},{"name":"Rare Cancers Clinic, Center for Specific Organs Cancer, National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cancer Center, Goyang, Korea"},{"name":"Center for Hematologic Malignancy, National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungnam","family":"Joo","sequence":"additional","affiliation":[{"name":"Biometrics Research Branch, Research Institute, National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weon Seo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihong","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Ok","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon-Seok","family":"Eom","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cancer Center, Goyang, Korea"},{"name":"Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea"},{"name":"Center for Hematologic Malignancy, National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1998.16.3.859","article-title":"Long-term survival in primary CNS lymphoma","volume":"16","author":"Yahalom","year":"1998","journal-title":"J Clin Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","article-title":"Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience","volume":"21","author":"Ponzoni","year":"2003","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajh.21849","article-title":"Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil\/lymphocyte ratio","volume":"85","author":"Markovic","year":"2010","journal-title":"Am J Hematol"},{"key":"4","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1038\/bjc.2014.163","article-title":"The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients","volume":"110","author":"Langsenlehner","year":"2014","journal-title":"Br J Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10428194.2015.1045897","article-title":"The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified","volume":"57","author":"Castillo","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3325\/cmj.2015.56.334","article-title":"Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study","volume":"56","author":"Barbi\u0107","year":"2015","journal-title":"Croat Med J"},{"key":"7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/bjc.2015.87","article-title":"Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour","volume":"113","author":"Prasad","year":"2015","journal-title":"Br J Cancer"},{"key":"8","first-page":"145619","article-title":"Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma","volume":"2014","author":"Eom","year":"2014","journal-title":"Biomed Res Int"},{"key":"9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/bjc.2013.763","article-title":"The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma","volume":"110","author":"Pichler","year":"2014","journal-title":"Br J Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3109\/10428194.2014.982642","article-title":"Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone","volume":"56","author":"Heo","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"11","first-page":"25","article-title":"Prognostic evaluation of neutrophil\/lymphocyte ratio in patients with mycosis fungoides","volume":"47","author":"Onsun","year":"2017","journal-title":"Ann Clin Lab Sci"},{"key":"12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jclinpath-2015-203356","article-title":"The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma","volume":"69","author":"Neumeister","year":"2016","journal-title":"J Clin Pathol"},{"key":"13","first-page":"e38209","article-title":"Comparison of the prognostic impact of neutrophil\/lymphocyte ratio, platelet\/lymphocyte ratio, and Glasgow prognostic score in diffuse large B-cell lymphoma","volume":"17","author":"Aurer","year":"2016","journal-title":"Shiraz E Med J"},{"key":"14","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/jcla.22004","article-title":"The prognostic significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients with multiple myeloma","volume":"30","author":"Varadi","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"15","doi-asserted-by":"crossref","first-page":"e993","DOI":"10.1097\/MD.0000000000000993","article-title":"Neutrophil\/lymphocyte ratio, lymphocyte\/monocyte ratio, and absolute lymphocyte count\/absolute monocyte count prognostic score in diffuse large B-cell lymphoma: useful prognostic tools in the rituximab era","volume":"94","author":"Wu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Werb","year":"2002","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2796.2000.00742.x","article-title":"Infections as a major preventable cause of human cancer","volume":"248","author":"Tricholpuolos","year":"2000","journal-title":"J Intern Med"},{"key":"18","first-page":"441","article-title":"Adaptive immunity in cancer immunology and therapeutics","volume":"8","author":"Lockley","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00262-007-0353-9","article-title":"Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma","volume":"57","author":"Griffioen","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"20","first-page":"1301","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Cascinelli","year":"1996","journal-title":"Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Green","year":"2011","journal-title":"J Clin Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Ritter","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","article-title":"Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer","volume":"14","author":"Busund","year":"2008","journal-title":"Clin Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Felding-Habermann","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3816\/CBC.2002.n.008","article-title":"Serum interleukin 6, plasma VEGF, serum VEGF, and VEFT platelet load in breast cancer patients","volume":"2","author":"Dirix","year":"2002","journal-title":"Clin Breast Cancer"},{"key":"26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00006676-200408000-00008","article-title":"The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents","volume":"29","author":"Kitajima","year":"2004","journal-title":"Pancreas"},{"key":"27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00000421-200304000-00007","article-title":"Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis","volume":"26","author":"Kyriakou","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1089\/10799900260286623","article-title":"Role of blood platelets in infection and inflammation","volume":"22","author":"Jelkmann","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10555-014-9498-0","article-title":"Platelets and cancer: a casual or causal relationship: revisited","volume":"33","author":"Honn","year":"2014","journal-title":"Cancer Metastasis Rev"},{"key":"30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2002-05-1576","article-title":"Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma","volume":"101","author":"Rosenbaum","year":"2003","journal-title":"Blood"},{"key":"31","first-page":"E1","article-title":"Molecular pathogenesis of primary central nervous system lymphoma","volume":"21","author":"Rubenstein","year":"2006","journal-title":"Neurosurg Focus"},{"key":"32","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0002-9440(10)65526-5","article-title":"Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment","volume":"155","author":"Deckert-Schl\u0171ter","year":"1999","journal-title":"Am J Pathol"},{"key":"33","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2007.13.5533","article-title":"Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Societe Francaise de Greffe de Moelle Osseuse-Therapie Cellulaire","volume":"26","author":"Omuro","year":"2008","journal-title":"J Clin Oncol"},{"key":"34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cncr.20339","article-title":"Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas","volume":"101","author":"Wu","year":"2004","journal-title":"Cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/ajh.24204","article-title":"Rituximab with high-dose methotrexate in primary central nervous system lymphoma","volume":"90","author":"Villa","year":"2015","journal-title":"Am J Hematol"},{"key":"36","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1212\/01.WNL.0000137050.43114.42","article-title":"Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide","volume":"63","author":"Abrey","year":"2004","journal-title":"Neurology"},{"key":"37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/WNL.0000000000000593","article-title":"High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma","volume":"83","author":"Ye","year":"2014","journal-title":"Neurology"},{"key":"38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood-2016-01-650101","article-title":"The role of whole brain radiation in primary CNS lymphoma","volume":"128","author":"Batchelor","year":"2016","journal-title":"Blood"},{"key":"39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.2012.076075","article-title":"Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation","volume":"98","author":"Klimm","year":"2013","journal-title":"Haematologica"},{"key":"40","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1200\/JCO.2005.07.109","article-title":"Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group","volume":"23","author":"Ponzoni","year":"2005","journal-title":"J Clin Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","article-title":"Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma","volume":"23","author":"Thiel","year":"2005","journal-title":"J Clin Oncol"},{"key":"42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-9473(98)00096-6","article-title":"An application of changepoint methods in studying the effect of ae on survival in breast cancer","volume":"30","author":"O'Quigley","year":"1999","journal-title":"Comput Stat Data Anal"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T11:44:57Z","timestamp":1589197497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":42,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2017,9,26]]}},"alternative-id":["20480","29088839"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20480","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,24]]}}}